Discovery of potent HIV-1 protease inhibitors incorporating sulfoximine functionality

A novel class of sulfoximine-based pseudosymmetric HIV-1 protease inhibitors were designed and synthesized. The most active isomer (2S,2′S) displays potent activity against HIV-1 protease as well as virus.